- 501. GC SEM VESICULIT (ACUTE)
- [ ] (UMLS (ICD9CM) C0578661) =Disease or Syndrome ;
| - 551. GEM 231/Paclitaxel
- (UMLS (NCI) C0796668) =Therapeutic or Preventive Procedure
|
- 502. GC SEM VESICULITIS, CHR
- [ ] (UMLS (ICD9CM) C0153205) =Disease or Syndrome
| - 552. GEM 91
- [A 25-mer antisense oligodeoxynucleotide phosphorothioate. GEM-91 is complementary to the gag mRNA of human immunodeficiency virus type 1 (HIV-1), resulting in HIV-1 replication inhibition. (NCI) ( NCI )] (UMLS (NCI) C0213960) =Nucleic Acid, Nucleoside, or Nucleotide; Pharmacologic Substance ;
|
- 503. gCAP 39
- [ ] (UMLS (CSP) C0599671) =Amino Acid, Peptide, or Protein; Biologically Active Substance ;
| - 553. GEM 92
- [A 25-mer antisense oligodeoxynucleotide phosphorothioate. GEM-92 is complementary to the gag mRNA of human immunodeficiency virus type 1 (HIV-1), resulting in HIV-1 replication inhibition. (NCI) ( NCI )] (UMLS (NCI) C1100101) Gene Expression Modulator 92 =Nucleic Acid, Nucleoside, or Nucleotide; Pharmacologic Substance
|
- 504. GCG
- [This gene is involved in glycogenolysis and gluconeogenesis regulation. ( NCI )] (UMLS (NCI) C1333664) GCG Gene;
Glucagon Gene =Gene or Genome ;
| - 554. Gemcitabine/ISIS 2503
- (UMLS (NCI) C0935714) =Therapeutic or Preventive Procedure
|
- 505. GCLC
- [This gene plays a role in the detoxification of endogenous reactive oxygen species. It is also involved in drug and xenobiotic metabolism. ( NCI )] (UMLS (NCI) C1415097) GCLC Gene;
Glutamate-Cysteine Ligase, Catalytic Subunit Gene =Gene or Genome | - 555. Gemcitabine/Ixabepilone
- (UMLS (NCI) C1327737) =Therapeutic or Preventive Procedure
|
- 506. GCLM
- [This gene is involved in the detoxification of endogenous reactive oxygen species. It also plays a role in drug and xenobiotic metabolism. ( NCI )] (UMLS (NCI) C1415098) GCLM Gene;
Glutamate-Cysteine Ligase, Modifier Subunit Gene =Gene or Genome | - 556. Gemcitabine/Lonafarnib
- (UMLS (NCI) C0935702) =Therapeutic or Preventive Procedure
|
- 507. Gcn5p
- [Gcn5p is a transcriptional coactivator required for correct expression of various genes in yeast. Several transcriptional regulators, including Gcn5p, possess intrinsic histone acetyltransferase (HAT) activity in vitro. ( NCI )] (UMLS (NCI) C1171569) =Amino Acid, Peptide, or Protein; Biologically Active Substance
| - 557. Gemcitabine/Mistletoe
- (UMLS (NCI) C1327797) =Therapeutic or Preventive Procedure ;
|
- 508. GD
- [An island between the Caribbean Sea and Atlantic Ocean, north of Trinidad and Tobago. (NCI) ( NCI )] (UMLS (NCI) C0018232) =Geographic Area ;
| - 558. Gemcitabine/Oblimersen
- (UMLS (NCI) C1327952) =Therapeutic or Preventive Procedure; ;
|
- 509. GDF10
- [This gene plays a role in skeletal morphogenesis and is involved in the regulation of cell growth. ( NCI )] (UMLS (NCI) C1333665) GDF10 Gene;
Growth Differentiation Factor 10 Gene =Gene or Genome ;
| - 559. Gemcitabine/Oxaliplatin
- (UMLS (NCI) C0879382) =Therapeutic or Preventive Procedure
|
- 510. GDF15
- [Expressed in activated, but not resting, macrophages and in placenta, prostate, colon, and kidney by human PLAB Gene (BMP/TGF-Beta Family), 308-aa 34-kDa (precursor) Placental TGF-Beta is processed at a dibasic cleavage site to release C-terminal domains containing a characteristic motif of 7 conserved cysteines in a disulfide-linked homodimeric secreted mature protein of 224 amino acids. PLAB regulates tissue differentiation and maintenance and reduces the growth of granulocytes and macrophages. Unlike most TGFB superfamily members, in which the amino acid sequence is completely conserved, PLAB shares only 70% amino acid identity with its rodent counterparts. (NCI) ( NCI )] (UMLS (NCI) C0668195) =Amino Acid, Peptide, or Protein; Biologically Active Substance ;
| - 560. Gemcitabine/Pemetrexed Disodium
- (UMLS (NCI) C0879558) =Therapeutic or Preventive Procedure
|
- 511. GDF15
- [This gene is involved in the regulation of tissue differentiation. It also plays a role in controlling the growth of granulocytes and macrophages. ( NCI )] (UMLS (NCI) C1335222) GDF15 Gene;
Growth Differentiation Factor 15 Gene =Gene or Genome ;
| - 561. Gemcitabine/Soblidotin
- (UMLS (NCI) C1328075) =Therapeutic or Preventive Procedure ;
|
- 512. GDF5
- [Growth Differentiation Factor 5, encoded by the human GDF5 gene, is a member of the bone morphogenetic protein (BMP) family and the TGF-beta superfamily. This protein is predominantly expressed in long bones during human embryonic development. Mutations in this gene are associated with acromesomelic dysplasia, Hunter-Thompson type; brachydactyly, type C; and chondrodysplasia, Grebe type. These associations confirm that the gene product plays a role in skeletal development. (From LocusLink, Swiss-Prot and NCI) ( NCI )] (UMLS (NCI) C0253373) =Amino Acid, Peptide, or Protein; Biologically Active Substance
| - 562. Gemcitabine/SU5416
- (UMLS (NCI) C0879564) =Therapeutic or Preventive Procedure
|
- 513. GDF5
- [This gene is involved in the regulation of axial bone growth during development and plays a role in cellular differentiation. ( NCI )] (UMLS (NCI) C1333666) GDF5 Gene;
Growth Differentiation Factor 5 Gene =Gene or Genome ;
| - 563. Gemcitabine/Suramin
- (UMLS (NCI) C1328023) =Therapeutic or Preventive Procedure; ;
|
- 514. GDF8
- [Growth Differentiation Factor 8, encoded by the human GDF8 gene, is a member of the bone morphogenetic protein (BMP) family and the TGF-beta superfamily. This protein plays a role in the control and maintenance of skeletal muscle mass. It acts specifically as a negative regulator of skeletal muscle growth by signaling through receptor serine/threonine kinases. This protein is synthesized as a preprotein activated by 2 proteolytic cleavages. Removal of the signal sequence is followed by cleavage at a tetrabasic processing site, resulting in a 26-kD amino-terminal propeptide and a 12.5-kD carboxy-terminal peptide, a dimer of which is the biologically active portion of the protein. (From LocusLink, OMIM and NCI) ( NCI )] (UMLS (NCI) C0538238) =Amino Acid, Peptide, or Protein; Biologically Active Substance
| - 564. Gemcitabine/UCN-01
- (UMLS (NCI) C1134677) =Therapeutic or Preventive Procedure
|
- 515. GDF8
- [This gene plays a role in cell differentiation and the regulation of transcription. It is also involved in the regulation of muscle mass. ( NCI )] (UMLS (NCI) C1333667) GDF8 Gene;
Growth Differentiation Factor 8 Gene =Gene or Genome ;
| - 565. Gemcitabine/Virulizin
- (UMLS (NCI) C1327756) =Therapeutic or Preventive Procedure; ;
|
- 516. GDF9
- [Growth Differentiation Factor 9, encoded by the human GDF9 gene, is a member of the TGF-beta superfamily. This protein interacts with bone morphogenetic protein-15 and Bone morphogenetic protein receptor type II is a receptor for Growth Differentiation Factor-9. Both GDF9 mRNA and protein are abundantly expressed in oocytes of primary follicles in human ovary, suggesting that the GDF9 transcript is translated at this early stage of folliculogenesis. GDF9 is crucial for normal ovarian folliculogenesis and female fertility. GDF9 regulates human folliculogenesis in a manner specific to the ovary. A dysregulation of GDF9 expression may contribute to aberrant folliculogenesis in PCOS and PCO women. (From OMIM, Swiss-Prot and NCI) ( NCI )] (UMLS (NCI) C0213144) =Amino Acid, Peptide, or Protein; Biologically Active Substance
| - 566. GEMFIBROZIL
- [lipid regulating agent that lowers elevated serum lipids primarily by decreasing serum triglycerides with a variable reduction in total cholesterol. ( CSP )] (UMLS (NCI) C0017245) =Lipid; Pharmacologic Substance =antihypercholesterolemic agent;
[CV350] ANTILIPEMIC AGENTS;
Pentanoic Acids;
carboxylate =GEMFIBROZIL 600 MG;
|
- 517. GDF9
- [This gene plays a role in ovarian folliculogenesis and normal ovulation. ( NCI )] (UMLS (NCI) C1333668) GDF9 Gene;
Growth Differentiation Factor 9 Gene =Gene or Genome ;
| - 567. Geminin
- [Encoded by human GMNN Gene (Geminin Family), 209-aa 24-kDa Geminin inhibits DNA replication during S, G2, and M phases by sequestering CDT1, a replication initiation factor necessary for MCM loading, to prevent the incorporation of MCM complex into prereplication complex. Geminin has a destruction box sequence (RRTLKVIQP) and is ubiquitinated by the anaphase-promoting complex. Geminin destruction at the metaphase-anaphase transition permits replication in the succeeding cell cycle. Geminin may also inhibit inappropriate origin firing by targeting CDT1. In the normal cell cycle, CDT1 is present only in G1 and S phases, whereas geminin is present in S and G2 phases. (NCI) ( NCI )] (UMLS (NCI) C0676272) =Amino Acid, Peptide, or Protein; Biologically Active Substance ;
|
- 518. GDNF
- [Glial cell derived neurotrophic factor enhances the survival and morphological differentiation of dopaminergic neurons and increases their uptake of dopamine. GDNF can rescue motor neurons from programmed cell death and death caused by axotomy. GDNF is a possible treatment for Parkinson disease because it can protect cells from the effect of the neurotoxin MPTP. GDNF is a ligand for the RET gene product and may contribute to Hirschsprung disease when mutated and combined with a mutant RET. (LocusLink) ( NCI )] (UMLS (NCI) C0207072) =Amino Acid, Peptide, or Protein; Biologically Active Substance ;
| - 568. Geminin, DNA Replication Inhibitor Gene
- [This gene plays a role in DNA replication regulation. ( NCI )] (UMLS (NCI) C1333683) GMNN;
GMNN Gene;
=Gene or Genome ;
|
- 519. GDNF
- [This gene is involved in neurogenesis. It plays a role in promoting the differential and survival of neurons. ( NCI )] (UMLS (NCI) C1333669) GDNF Gene;
Glial Cell Derived Neurotrophic Factor Gene =Gene or Genome ;
| - 569. Geminivirus
- [A family of plant viruses where the VIRION possesses an unusual morphology consisting of a pair of isometric particles. Transmission occurs via leafhoppers or whitefly. Some viruses cause economically important diseases in cultivated plants. There are four genera: Mastrevirus, Curtovirus, Topocuvirus, and BEGOMOVIRUS. ( MSH )] (UMLS (CSP) C0206262) =Virus ;
|
- 520. GDNF Family Receptor Alpha 2
- [GDNF Family Receptor Alpha 2, encoded by the human GFRA2 gene, is a member of the Glial Cell Line-Derived Neurotrophic Factor (GDNF) Receptor family. GDNF and neurturin (NTN) are two structurally related, potent neurotrophic factors that play key roles in the control of neuron survival and differentiation. GFRA2 is required for the development of the myenteric nerve plexus. This protein is a glycosylphosphatidylinositol(GPI)-linked cell surface receptor for both GDNF and NTN, and mediates activation of the RET tyrosine kinase receptor. This receptor acts preferentially as a receptor for NTN compared to its other family member, GDNF Family Receptor Alpha 1. Two alternatively spliced transcript variants, long and short, have been described for this gene but their full length nature is not known. The short form is found in brain and placenta. This gene is a candidate gene for RET-associated diseases. (From LocusLink, OMIM, Swiss-Prot and NCI) ( NCI )] (UMLS (NCI) C1457885) GDNF Family Receptor Alpha-2;
GDNF Receptor Beta;
GDNFRB;
GDNFR-Beta;
GFRA2;
GFRA2 Protein;
GFR-Alpha 2;
Glial Cell Line Derived Neurotrophic Factor Receptor, Beta;
Glial Cell Line-Derived Neurotrophic Factor Receptor Beta;
Neurturin Receptor Alpha;
NRTNR-ALPHA;
NTNRA;
NTNR-Alpha;
PI-Linked Cell-Surface Accessory Protein;
RET Ligand 2;
RETL2;
TGF-Beta Related Neurotrophic Factor Receptor 2;
TRN Receptor, GPI-Anchored;
TRNR2;
=Amino Acid, Peptide, or Protein; Receptor | - 570. Gemistocyte
- [A pathologic astrocyte in which the cell body swells and contains glial filaments and an eccentric nucleus; seen particularly in demyelinating and neoplastic conditions. ( NCI )] (UMLS (NCI) C0333735) =Cell ;
|
- 521. GDNF Family Receptor Alpha 2 Gene
- [This gene plays a regulatory role in neuronal survival and differentiation. ( NCI )] (UMLS (NCI) C1333672) GFRA2;
GFRA2 Gene =Gene or Genome ;
| - 571. Gemistocytic Astrocytoma
- [A rare variant of Diffuse Astrocytoma. It is characterized by the presence of a conspicuous, though variable, fraction of gemistocytic neoplastic astrocytes. Gemistocytes are round to oval astrocytes with abundant, glassy, non-fibrillary cytoplasm which appears to displace the dark, angulated nucleus to the periphery of the cell. To make the diagnosis of gemistocytic astrocytoma, gemistocytes should amount to more than approximately 20% of all tumor cells. (Adapted from WHO.) ( NCI )] (UMLS (NCI) C0334581) =Neoplastic Process
|
- 522. GDP
- [guanosine 5'-(trihydrogen diphosphate); guanine nucleotide containing two phosphate groups esterified to the sugar moiety. ( CSP )] (UMLS (NCI) C0018340) =Nucleic Acid, Nucleoside, or Nucleotide; Biologically Active Substance ;
=guanine nucleotide;
| - 572. Gemtuzumab Ozogamicin/Oblimersen
- (UMLS (NCI) C1134605) =Therapeutic or Preventive Procedure
|
- 523. GE
- [A country in Southwestern Asia, bordering the Black Sea, between Turkey and Russia. (NCI) ( NCI )] (UMLS (NCI) C0017454) =Geographic Area
| - 573. gemzar
- [ ] (UMLS (CSP) C0338133) =Nucleic Acid, Nucleoside, or Nucleotide; Pharmacologic Substance
|
- 524. GE
- [A statement about the relative size or order of two objects specifying that either both objects are the same in quantity or measure or value or status or that the object of interest exceeds the other object in one of these ways. ( NCI )] (UMLS (NCI) C0439091) =Intellectual Product =Relational operator;
RelationalOperator | - 574. GEN CNV EPIL W INTR EPIL
- [ ] (UMLS (ICD9CM) C0154710) =Disease or Syndrome
|
- 525. Ge element
- [rare metal element with a blue-gray appearance, atomic symbol Ge, atomic number 32, and atomic weight 72.59. ( CSP )] (UMLS (CSP) C0017479) =Element, Ion, or Isotope ;
=heavy metal;
| - 575. GEN CNV EPIL W/O INTR EP
- [ ] (UMLS (ICD9CM) C0154709) =Disease or Syndrome
|
- 526. Gefitinib/Oxaliplatin
- (UMLS (NCI) C1134507) =Therapeutic or Preventive Procedure
| - 576. GEN NONCONV EP W INTR EP
- (UMLS (ICD9CM) C1112693) Generalized nonconvulsive epilepsy, with intractable epilepsy =Disease or Syndrome ;
|
- 527. Gefitinib/Tamoxifen
- (UMLS (NCI) C1328132) =Therapeutic or Preventive Procedure ;
| - 577. GEN NONCV EP W/O INTR EP
- [ ] (UMLS (ICD9CM) C0154707) =Disease or Syndrome
|
- 528. Gefitinib/Temozolomide
- (UMLS (NCI) C1134534) =Therapeutic or Preventive Procedure
| - 578. GEN OSTEOARTHROS-HAND
- [ ] (UMLS (ICD9CM) C0157924) =Disease or Syndrome
|
- 529. Gefitinib/Trastuzumab
- (UMLS (NCI) C1134483) =Therapeutic or Preventive Procedure
| - 579. GEN PSYCHIATRIC EXAM NEC
- [ ] (UMLS (ICD9CM) C0302434) =Finding
|
- 530. gel
- [colloidal suspension of a liquid in a solid; firm in consistency. ( CSP )] (UMLS (CSP) C1382104) =Substance =physical state;
| - 580. GEN VISUAL CONTRACTION
- [ ] (UMLS (ICD9CM) C0155012) =Disease or Syndrome
|
- 531. Gel
- [A gelatinous type of separator material. ( HL7V3.0 )] (UMLS (HL7) C1551386) =Manufactured Object =ContainerSeparator;
| - 581. Genasense
- (UMLS (NCI) C0935954) =Nucleic Acid, Nucleoside, or Nucleotide; Pharmacologic Substance ;
|
- 532. GEL
- [A semisolid (1) dosage form that contains a gelling agent to provide stiffness to a solution or a colloidal dispersion (2). A gel may contain suspended particles. Note 1: A semisolid is not pourable; it does not flow or conform to its container at room temperature. It does not flow at low shear stress and generally exhibits plastic flow behavior. Note 2: A colloidal dispersion is a system in which particles of colloidal dimension (i.e., typically between 1 nm and 1 micrometer) are distributed uniformly throughout a liquid. (NCI) ( NCI )] (UMLS (NCI) C0017243) =Biomedical or Dental Material ;
=Solid;
LiquidSolidSuspension =Vaginal Gel;
Nasal Gel;
Ophthalmic Gel;
Oral Gel;
Rectal Gel;
Topical Gel;
Urethral Gel;
Gel with Applicator;
Vaginal Gel;
Nasal Gel;
Ophthalmic Gel;
Topical Gel;
Urethral Gel;
Otic Gel;
Gel with Applicator;
| - 582. Genbank
- [The NIH genetic sequence database, an annotated collection of all publicly available DNA sequences. GenBank records are annotated using a standard set of biological terms and show these annotations in a Feature Table. ( NCI )] (UMLS (CSP) C0598211) =Intellectual Product
|
- 533. gel electrophoresis
- [electrochemical process in which macromolecules or colloidal particles with a net electric charge migrate in a gel under the influence of an electric current. ( CSP )] (UMLS (CSP) C0596607) =Laboratory Procedure =electrophoresis;
=2 Dimensional Gel Electrophoresis;
Electrophoresis, Gel, Pulsed-Field;
gel mobility shift assay;
denaturing gradient gel electrophoresis;
SDS PAGE | - 583. GEND IDEN DIS,ADOL/ADULT
- [ ] (UMLS (ICD9CM) C0154467) =Mental or Behavioral Dysfunction
|
- 534. gel filtration chromatography
- [column chromatography that separates compounds on the basis of molecular size by using a molecular sieve, usually a zeolite; molecules larger than the largest pore size are excluded from the column. ( CSP )] (UMLS (CSP) C0008559) =Laboratory Procedure ;
=chromatography;
molecular sieving | - 584. gender
- [The assemblage of properties that distinguish people on the basis of their societal roles. ( NCI )] (UMLS (CSP) C0079399) =Organism Attribute ;
=Demographic states;
=F;
Human, Male |
- 535. gel microdrop encapsulation
- [ ] (UMLS (CSP) C1113666) =Laboratory Procedure
| - 585. Gender Alert
- [Proposed therapy may be inappropriate or contraindicated due to patient gender. ( HL7V3.0 )] (UMLS (HL7) C1553538) =Intellectual Product =Observation Alert;
|
- 536. gel mobility shift assay
- [gel electrophoresis of DNA in the presence of DNA binding proteins changes the migration relative to homologous protein-free DNA, and can be used to detect the presence and specificity of the proteins. ( CSP )] (UMLS (CSP) C0596608) =Diagnostic Procedure =genetic technique;
gel electrophoresis | - 586. gender difference
- [characteristics or qualities that distinguish one sex from the other; qualities, conditions, disorders, etc., which contribute to similarities and differences between sexes. ( CSP )] (UMLS (CSP) C0036866) =Organism Attribute =Sex;
|
- 537. gel retardation assay
- [ ] (UMLS (CSP) C0598490) =Laboratory Procedure ;
| - 587. Gender identity disorder in children
- (UMLS (ICD9CM) C0236802) =Mental or Behavioral Dysfunction
|
- 538. gelada baboon
- [ ] (UMLS (CSP) C0039827) =Mammal
| - 588. Gender of patient(s)
- (UMLS (HL7) C1548569) =Intellectual Product =Location characteristic ID;
|
- 539. gelatin
- [soluble protein produced by boiling collagen in water. ( CSP )] (UMLS (CSP) C0017237) =Amino Acid, Peptide, or Protein; Biomedical or Dental Material =scleroprotein;
fibrous protein;
Inactive Ingredient Preparations;
=Absorbable Gelatin Sponge;
Stomahesive;
ORABASE PLAIN PASTE;
Benzocaine 0.2 MG/MG Toothpaste;
Dextromethorphan 15 MG / Pseudoephedrine 30 MG Chewable Tablet;
Dextromethorphan 15 MG Chewable Tablet;
EMPTY GELATIN CAP,CLEAR SZ 0;
EMPTY GELATIN CAP,CLEAR SZ 000;
EMPTY GELATIN CAP,CLEAR SZ 1;
EMPTY GELATIN CAP,CLEAR SZ 2;
EMPTY GELATIN CAP,CLEAR SZ 4;
FEMIRON VITAMIN TAB;
ITRACONAZOLE 100 MG Oral (systemic) capsule;
QUINAPRIL 10 MG / QUINAPRIL HYDROCHLORIDE ORAL TABLET, FILM COATED;
quinapril 20 MG Oral Tablet;
quinapril 5 MG Oral Tablet;
EMPTY GELATIN CAP,CLEAR SZ 3;
QUINAPRIL 40 MG ORAL TABLET;
GELATIN 650 MG;
EMPTY GELATIN CAP,CLEAR SZ 00;
GELATIN 600 MG;
GELATIN 1.1 % | - 589. gender preference
- [ ] (UMLS (CSP) C0036891) =Mental Process; Individual Behavior
|
- 540. GELATIN
- (UMLS (NCI) C1145617) =Food ;
| - 590. gender role
- [behavioral patterns expected from individuals by their social group believed to be typical of their sex; certain behavior patterns are culturally influenced, such as ascendance submissiveness, or occupational choices; sex role is often called psychosexual role. ( CSP )] (UMLS (CSP) C0017253) =Social Behavior ;
=role;
Sex Behavior |
- 541. gelatinase
- [A class of enzymes that catalyzes the degradation of gelatin by acting on the peptide bonds. EC 3.4.24.-. ( MSH )] (UMLS (CSP) C0206528) =Amino Acid, Peptide, or Protein; Enzyme
| - 591. GenderStatus
- (UMLS (HL7) C1553822) =Intellectual Product =CodeSystem;
=Neutered;
Intact |
- 542. Gelatinase B
- [Proteins of the matrix metalloproteinase (MMP) family are involved in the breakdown of extracellular matrix in normal physiological processes, such as embryonic development, reproduction, and tissue remodeling, as well as in disease processes, such as arthritis and metastasis. Most MMP's are secreted as inactive proproteins which are activated when cleaved by extracellular proteinases. This enzyme degrades type IV and V collagens. Studies in rhesus monkeys suggest that the enzyme is involved in IL-8-induced mobilization of hematopoietic progenitor cells from bone marrow, and murine studies suggest a role in tumor-associated tissue remodeling. (from LocusLink) ( NCI )] (UMLS (NCI) C0165519) =Amino Acid, Peptide, or Protein; Enzyme
| - 592. gene
- [segment of the genome that codes for a functional product. ( CSP )] (UMLS (NCI) C0017337) =Gene or Genome =Molecular Genetics;
=allele;
lethal gene;
structural gene;
Intervening Sequence;
Cancer-Promoting Gene;
operon;
Cellular Oncogene;
genetic regulatory element;
antioncogene;
IS (insertion sequence);
histocompatibility gene;
QTL;
fusion gene;
parkin gene/protein;
sonic hedgehog gene/protein;
|
- 543. Gelatinous Ascites
- [(SOO-doe-mix-O-ma PAIR-ih-TOE-nee-I) A build-up of mucus in the peritoneal cavity. The mucus may come from ruptured ovarian cysts, the appendix, or from other abdominal tissues, and mucus-secreting cells may attach to the peritoneal lining and continue to secrete mucus. ( NCI )] (UMLS (NCI) C0033822) =Neoplastic Process =Neoplasms, Cystic, Mucinous, and Serous;
| - 593. gene activation
- [ ] (UMLS (CSP) C0017255) =Genetic Function ;
|
- 544. Gelclair
- (UMLS (NCI) C1098961) =Organic Chemical; Pharmacologic Substance ;
| - 594. Gene Amplification
- [natural process where genes are reproduced into multiple copies to speed up expression; do NOT use this term to cover cloning or PCR. ( CSP )] (UMLS (NCI) C0017256) =Genetic Function ;
=Molecular Genetics;
|
- 545. Geldanamycin Analog
- [An antineoplastic antibiotic drug that belongs to the family of drugs called ansamycins. ( NCI )] (UMLS (NCI) C0796552) geldanamycin analogue =Organic Chemical; Antibiotic ;
| - 595. gene attenuator
- [ ] (UMLS (CSP) C0598511) =Genetic Function ;
|
- 546. Gelfoam
- (UMLS (NCI) C0918040) =Medical Device
| - 596. gene chip
- [ ] (UMLS (CSP) C0872345) =Medical Device; Research Device
|
- 547. Gelineau's syndrome
- [recurrent, uncontrollable brief episodes of sleep and lapses in consciousness, often associated with hypnagogic hallucinations, cataplexy, automatic behaviors and sleep paralysis. ( CSP )] (UMLS (CSP) C0027404) =Disease or Syndrome ;
=Central Nervous System Disease;
Disorders of Excessive Somnolence =cataplexy;
| - 597. gene cloning
- [The insertion of a DNA sequence into a vector that can then be propagated in a host organism, generating a large number of copies of the sequence. ( NCI )] (UMLS (CSP) C0598888) =Laboratory Procedure; Molecular Biology Research Technique
|
- 548. gelsolin
- [calcium activated, actin capping protein found in ameboid cells that favors depolymerization of microtubules and therefore the sol state in gel-sol cytoplasmic streaming. ( CSP )] (UMLS (CSP) C0061187) =Amino Acid, Peptide, or Protein; Biologically Active Substance ;
=ABP;
| - 598. gene complementation
- [the restoration of wild-type function by two different mutations brought together in the same cell; interaction between two genetic units, one or both of which are defective, permitting the organism containing these units to function normally, whereas it could not do so if either unit were absent. ( CSP )] (UMLS (CSP) C0178654) =Genetic Function; Molecular Biology Research Technique ;
=gene interaction;
|
- 549. GEM 132
- [A 20-mer mixed backbone oligonucleotide exhibiting anti-viral activity. GEM-132 is comprised of a strand of synthetic DNA with a modified RNA at each end (2-O-methylribonucleosides at the two 3- and four 5-terminal nucleotides) which is complementary to the intron-exon boundary of the UL35 and UL37 premRNA transcripts of human cytomegalovirus. (NCI) ( NCI )] (UMLS (NCI) C0667539) =Nucleic Acid, Nucleoside, or Nucleotide; Pharmacologic Substance ;
| - 599. gene conservation
- [ ] (UMLS (CSP) C0599698) =Functional Concept ;
|
- 550. GEM 231
- [A drug that may inhibit the growth of malignant tumors. ( NCI )] (UMLS (NCI) C0677981) =Nucleic Acid, Nucleoside, or Nucleotide; Pharmacologic Substance ;
| - 600. gene conversion
- [the asymmetrical segregation of genes during replication which leads to the production of non-reciprocal recombinant strands and the apparent conversion of one allele into another. ( CSP )] (UMLS (CSP) C0017259) =Genetic Function ;
=DNA Recombination;
|
home
